Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study

Documenti analoghi

• Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension
  di: Cara Morgan, et al.
  Pubblicazione: (2024)
• Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension
  di: Tejaswini P. Reddy, et al.
  Pubblicazione: (2024)
• Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
  di: André Carramenha de Góes Hirano
  Pubblicazione: (2017)
• Right ventricular stroke work index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A retrospective observational study
  di: Györgyi Csósza, et al.
  Pubblicazione: (2024)
• Editorial on “Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension”
  di: Lindsay M. Forbes
  Pubblicazione: (2024)